Vaxcyte Inc
NASDAQ:PCVX

Watchlist Manager
Vaxcyte Inc Logo
Vaxcyte Inc
NASDAQ:PCVX
Watchlist
Price: 31.16 USD -0.92% Market Closed
Market Cap: 4B USD

Vaxcyte Inc
Investor Relations

Vaxcyte Inc. has carved a niche in the biotechnology industry with its focus on developing next-generation vaccines to tackle some of the most challenging infectious diseases. The company, headquartered in San Carlos, California, leverages its proprietary cell-free protein synthesis platform, XpressCF™, which enables the rapid production of complex proteins at scale. This technology forms the backbone of its vaccine development process, allowing Vaxcyte to bypass traditional cell-based methods that can be both time-consuming and costly. At the core of Vaxcyte's mission is its commitment to addressing unmet medical needs by enhancing the efficacy and safety profiles of vaccines, ultimately aiming to deliver superior alternatives to existing products on the market.

Vaxcyte's business model is built on a strategic blend of research and development, partnerships, and intellectual property. The company invests heavily in R&D to advance its pipeline of vaccine candidates, with a particular emphasis on conjugate vaccines targeting bacterial infections such as pneumococcal diseases. Revenue generation is primarily driven through collaborations and licensing agreements with larger pharmaceutical companies that provide upfront payments, milestones, and potential royalties. These partnerships not only validate Vaxcyte’s scientific approach but also furnish the essential capital to sustain its innovative programs and bring its cutting-edge vaccines to market. As Vaxcyte continues to make strides in vaccine development, the company positions itself as a key player in the quest for more effective disease prevention solutions.

Show more
Loading

Earnings Calls

Show Transcript
Previous
Next
Loading

Management

Mr. Grant E. Pickering M.B.A.
Co-Founder, CEO & Director
No Bio Available
Mr. Andrew L. Guggenhime M.B.A.
President & CFO
No Bio Available
Mr. James Wassil M.B.A., M.S.
Executive VP & COO
No Bio Available
Dr. Ashish Khanna M.B.A., Ph.D.
Co-Founder
No Bio Available
Dr. Jeff Fairman Ph.D.
Co-Founder & VP of Research
No Bio Available
Ms. Elvia Cowan
Senior VP of Finance & Principal Accounting Officer
No Bio Available
Ms. Janet Graesser
Senior Vice President of Corporate Communications & Investor Relations
No Bio Available
Ms. Whitney Jones
Chief People Officer
No Bio Available
Mr. Paul W. Sauer M.B.A.
Senior Vice President of Process Development & Manufacturing
No Bio Available
Mr. Harp Dhaliwal M.B.A.
Senior Vice President of Commercial Manufacturing & Supply Chain
No Bio Available

Contacts

Address
CALIFORNIA
San Carlos
825 Industrial Road, Ste. 300
Contacts
+16508370111.0
vaxcyte.com